Is Compounded Semaglutide Safe?

By StayPrime Editorial | 5 min read

StayPrime is not a medical provider and does not prescribe medication. This information is educational only and is not medical advice. Talk to a licensed clinician about whether a GLP-1 medication is appropriate for you.

Compounded semaglutide costs less than branded Wegovy and is widely available through telehealth. It also is not FDA-approved. Both of those things are true at the same time, and understanding why is the key to deciding whether it is right for you.

What "compounded" actually means

Compounding is the legal practice of a state-licensed pharmacy preparing a medication tailored to a specific patient's needs, when an FDA-approved version is not appropriate or not available. It has existed for over a century and is governed by sections 503A and 503B of the federal Food, Drug, and Cosmetic Act.

Compounded medications are not FDA-approved. The FDA evaluates and approves specific products from specific manufacturers; a compounded preparation is, by definition, not that. State pharmacy boards license and inspect compounding pharmacies, but the level of oversight varies.

Why compounded GLP-1s are even legal right now

Branded semaglutide and tirzepatide have been on the FDA's official drug-shortage list for portions of the past few years. During an official shortage, the FDA's enforcement discretion allows licensed pharmacies to compound versions of those medications. When a shortage ends, that allowance is supposed to wind down. The legal landscape around compounded GLP-1s has been actively contested in court.

The real risks

Compounded preparations vary across pharmacies. Specific risks worth understanding before you sign up:

• Different active ingredient form. Some compounded products use semaglutide salts (acetate, sodium) rather than the base form used in branded Ozempic and Wegovy. Salt forms are not bioequivalent to the branded version and the long-term data on them is thin.
• Different inactive ingredients. The carriers, preservatives, and pH balance can differ pharmacy to pharmacy.
• Variable testing. Compounded products are not subject to the same potency, sterility, and stability testing as approved drugs.
• Limited reporting. Adverse events with compounded products are not centrally collected the way branded-drug events are.

The FDA has issued safety alerts about specific compounded GLP-1 products. None of this means compounded semaglutide is automatically unsafe, but it does mean the safety floor is the pharmacy you are buying from, not a federal review.

Questions to ask before signing up

• What pharmacy fills the prescription? Is it state-licensed and, ideally, registered as a 503B outsourcing facility?
• Is the active ingredient base semaglutide or a salt form?
• What testing is performed on each lot for potency and sterility?
• How is the prescription written: by a provider licensed in your state who has reviewed your medical history, or by an algorithm?
• What is the program's policy if you have side effects?

The bottom line

Compounded semaglutide is a real, regulated product, not an underground market. It is also not the same product as Wegovy. The cost difference is meaningful and so is the regulatory difference. Talk to a provider you trust, ask the questions above, and make the call with eyes open.

Sources

1. U.S. FDA. Drug Compounding and FDA: Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
2. U.S. FDA. Drug Shortages list.
3. U.S. FDA. Compounded Drugs and Patient Safety: Compounded Semaglutide and Tirzepatide.

Find a trainer who works with GLP-1 clients | More GLP-1 guides